Save time and get answers to complex questions with AI chat
Motegrity ingredients?Guselkumab loss of exclusitivy?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Does lipitor's use influence blood pressure medication type?What's the recommended schedule for lurbinectedin side effect checks?
See the DrugPatentWatch profile for Pramlintide
Pramlintide (brand name Symlin) received FDA approval on March 29, 2005. [1]
Pramlintide is a synthetic analog of the hormone amylin. It was approved as an adjunct to mealtime insulin in people with diabetes, as reflected in FDA labeling and approval records. [1]
You can cross-check the date in DrugPatentWatch’s drug record for Symlin (pramlintide). [1] Sources: [1] https://www.drugpatentwatch.com/patent/US-pramlintide
Other Questions About Pramlintide :